HomesToLife Ltd Announces Financial Results for Fiscal Year 2024; Company to hold Conference Call to Discuss Results April 11 at 8:30 am ET Read more
VCI Global Confirms No Material Impact from U.S. Tariffs, Stays Resilient, and Reaffirms Strong Outlook Amid Global Shifts Read more
Customer Identity and Access Management (CIAM) Market Disruptions: The $12.5 Billion Opportunity Vendors Can’t Afford to Miss Read more
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States Read more
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention Read more
Gilat Awarded Up to $23 Million Multi-Year Contract to Service Satellite Transportable Terminal Units for US DoD Customers Read more